Cargando…

Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria

Dementia with Lewy bodies (DLB) is an insidious neurodegenerative disease characterised by a precipitous decline in cognition, sleep disturbances, motor impairment and psychiatric features. Recently, criteria for prodromal DLB (pDLB) including clinical features and biomarkers have been put forward t...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, Joseph R., Matar, Elie, Ehgoetz Martens, Kaylena A., Moustafa, Ahmed A., Halliday, Glenda M., Lewis, Simon J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775171/
https://www.ncbi.nlm.nih.gov/pubmed/36552054
http://dx.doi.org/10.3390/brainsci12121594
_version_ 1784855578542080000
author Phillips, Joseph R.
Matar, Elie
Ehgoetz Martens, Kaylena A.
Moustafa, Ahmed A.
Halliday, Glenda M.
Lewis, Simon J. G.
author_facet Phillips, Joseph R.
Matar, Elie
Ehgoetz Martens, Kaylena A.
Moustafa, Ahmed A.
Halliday, Glenda M.
Lewis, Simon J. G.
author_sort Phillips, Joseph R.
collection PubMed
description Dementia with Lewy bodies (DLB) is an insidious neurodegenerative disease characterised by a precipitous decline in cognition, sleep disturbances, motor impairment and psychiatric features. Recently, criteria for prodromal DLB (pDLB) including clinical features and biomarkers have been put forward to aid the classification and research of this ambiguous cohort of patients. Researchers can use these criteria to classify patients with mild cognitive impairment (MCI) with Lewy bodies (MCI-LB) as either possible (either one core clinical feature or one biomarker are present) or probable pDLB (at least two core clinical features, or one core clinical feature and at least one biomarker present). However, as isolated REM sleep behaviour disorder (iRBD) confirmed with polysomnography (PSG) can be included as both a clinical and a biomarker feature, potentially reducing the specificity of these diagnostic criteria. To address this issue, the current study classified a cohort of 47 PSG-confirmed iRBD patients as probable prodromal DLB only in the presence of an additional core feature or if there was an additional non-PSG biomarker. Thirteen iRBD patients demonstrated MCI (iRBD-MCI). In the iRBD-MCI group, one presented with parkinsonism and was thus classified as probable pDLB, whilst the remaining 12 were classified as only possible pDLB. All patients performed three tasks designed to measure attentional deficits, visual hallucinations and visuospatial impairment. Patients also attended clinical follow-ups to monitor for transition to DLB or another synucleinopathy. Findings indicated that the only patient categorised by virtue of having two core clinical features as probable pDLB transitioned over 28 months to a diagnosis of DLB. The performance of this probable pDLB patient was also ranked second-highest for their hallucinatory behaviours and had comparatively lower visuospatial accuracy. These findings highlight the need for more stringent diagnostic research criteria for pDLB, given that only one of the 13 patients who would have satisfied the current guidelines for probable pDLB transitioned to DLB after two years and was indeed the patient with two orthogonal core clinical features.
format Online
Article
Text
id pubmed-9775171
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97751712022-12-23 Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria Phillips, Joseph R. Matar, Elie Ehgoetz Martens, Kaylena A. Moustafa, Ahmed A. Halliday, Glenda M. Lewis, Simon J. G. Brain Sci Article Dementia with Lewy bodies (DLB) is an insidious neurodegenerative disease characterised by a precipitous decline in cognition, sleep disturbances, motor impairment and psychiatric features. Recently, criteria for prodromal DLB (pDLB) including clinical features and biomarkers have been put forward to aid the classification and research of this ambiguous cohort of patients. Researchers can use these criteria to classify patients with mild cognitive impairment (MCI) with Lewy bodies (MCI-LB) as either possible (either one core clinical feature or one biomarker are present) or probable pDLB (at least two core clinical features, or one core clinical feature and at least one biomarker present). However, as isolated REM sleep behaviour disorder (iRBD) confirmed with polysomnography (PSG) can be included as both a clinical and a biomarker feature, potentially reducing the specificity of these diagnostic criteria. To address this issue, the current study classified a cohort of 47 PSG-confirmed iRBD patients as probable prodromal DLB only in the presence of an additional core feature or if there was an additional non-PSG biomarker. Thirteen iRBD patients demonstrated MCI (iRBD-MCI). In the iRBD-MCI group, one presented with parkinsonism and was thus classified as probable pDLB, whilst the remaining 12 were classified as only possible pDLB. All patients performed three tasks designed to measure attentional deficits, visual hallucinations and visuospatial impairment. Patients also attended clinical follow-ups to monitor for transition to DLB or another synucleinopathy. Findings indicated that the only patient categorised by virtue of having two core clinical features as probable pDLB transitioned over 28 months to a diagnosis of DLB. The performance of this probable pDLB patient was also ranked second-highest for their hallucinatory behaviours and had comparatively lower visuospatial accuracy. These findings highlight the need for more stringent diagnostic research criteria for pDLB, given that only one of the 13 patients who would have satisfied the current guidelines for probable pDLB transitioned to DLB after two years and was indeed the patient with two orthogonal core clinical features. MDPI 2022-11-22 /pmc/articles/PMC9775171/ /pubmed/36552054 http://dx.doi.org/10.3390/brainsci12121594 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Phillips, Joseph R.
Matar, Elie
Ehgoetz Martens, Kaylena A.
Moustafa, Ahmed A.
Halliday, Glenda M.
Lewis, Simon J. G.
Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
title Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
title_full Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
title_fullStr Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
title_full_unstemmed Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
title_short Exploring the Sensitivity of Prodromal Dementia with Lewy Bodies Research Criteria
title_sort exploring the sensitivity of prodromal dementia with lewy bodies research criteria
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775171/
https://www.ncbi.nlm.nih.gov/pubmed/36552054
http://dx.doi.org/10.3390/brainsci12121594
work_keys_str_mv AT phillipsjosephr exploringthesensitivityofprodromaldementiawithlewybodiesresearchcriteria
AT matarelie exploringthesensitivityofprodromaldementiawithlewybodiesresearchcriteria
AT ehgoetzmartenskaylenaa exploringthesensitivityofprodromaldementiawithlewybodiesresearchcriteria
AT moustafaahmeda exploringthesensitivityofprodromaldementiawithlewybodiesresearchcriteria
AT hallidayglendam exploringthesensitivityofprodromaldementiawithlewybodiesresearchcriteria
AT lewissimonjg exploringthesensitivityofprodromaldementiawithlewybodiesresearchcriteria